Oxygen-ozone (O(2)-O(3)) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported

OBJECTIVE: This study evaluated the potential efficacy of a novel approach to treat COVID-19 patients, using an oxygen-ozone (O(2)-O(3)) mixture, via a process called Oxygen-Ozone- Immunoceutical Therapy. The methodology met the criteria of a novel, promising approach to treat successfully elderly C...

Descripción completa

Detalles Bibliográficos
Autores principales: Franzini, Marianno, Valdenassi, Luigi, Ricevuti, Giovanni, Chirumbolo, Salvatore, Depfenhart, Markus, Bertossi, Dario, Tirelli, Umberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414302/
https://www.ncbi.nlm.nih.gov/pubmed/32795898
http://dx.doi.org/10.1016/j.intimp.2020.106879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414302/
https://www.ncbi.nlm.nih.gov/pubmed/32795898
http://dx.doi.org/10.1016/j.intimp.2020.106879

Ejemplares similares